SEATTLE GENETICS INC (60) | Uncategorized (6)

Recent Contracts

Amendment to Joint Commercialization Agreement between Seagen Inc. and Agensys, Inc. effective January 1, 2020 (Filed With SEC on July 29, 2021)
Letter Agreement Regarding Royalty between the University of Miami and Seagen Inc. (f/k/a (Filed With SEC on July 29, 2021)
Joint Commercialization Agreement dated October 19, 2020 between Genmab A/S and Seagen Inc. (f.k.a. Seattle Genetics Inc.) (Filed With SEC on February 12, 2021)
Amendment No. 1 (Filed With SEC on July 31, 2020)
Description of Securities of Seattle Genetics, Inc (Filed With SEC on February 6, 2020)
Joint Commercialization Agreement dated October 20, 2018 between Seattle Genetics, Inc. and Agensys, Inc (Filed With SEC on July 16, 2019)